Precigen Enterprise Value Multiple from 2010 to 2024

PGEN Stock  USD 0.91  0.05  5.81%   
Precigen Enterprise Value Multiple yearly trend continues to be very stable with very little volatility. Enterprise Value Multiple is likely to drop to -3.85. During the period from 2010 to 2024, Precigen Enterprise Value Multiple quarterly data regression pattern had range of 45.4741 and standard deviation of  14.01. View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
(3.67)
Current Value
(3.85)
Quarterly Volatility
14.0070465
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Precigen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Precigen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.3 M, Interest Expense of 444.6 K or Total Revenue of 5.9 M, as well as many indicators such as Price To Sales Ratio of 55.27, Dividend Yield of 0.0 or PTB Ratio of 4.45. Precigen financial statements analysis is a perfect complement when working with Precigen Valuation or Volatility modules.
  
Check out the analysis of Precigen Correlation against competitors.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

Latest Precigen's Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Precigen over the last few years. It is Precigen's Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Precigen's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Pretty Stable
   Enterprise Value Multiple   
       Timeline  

Precigen Enterprise Value Multiple Regression Statistics

Arithmetic Mean(13.47)
Coefficient Of Variation(104.00)
Mean Deviation11.09
Median(7.47)
Standard Deviation14.01
Sample Variance196.20
Range45.4741
R-Value0.15
Mean Square Error206.45
R-Squared0.02
Significance0.59
Slope0.47
Total Sum of Squares2,747

Precigen Enterprise Value Multiple History

2024 -3.85
2023 -3.67
2022 -5.32
2021 -10.53
2020 -26.05
2019 -7.47
2018 -2.74

About Precigen Financial Statements

Precigen investors utilize fundamental indicators, such as Enterprise Value Multiple, to predict how Precigen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Multiple(3.67)(3.85)

Pair Trading with Precigen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Precigen Stock

  0.73FDMT 4D Molecular TherapeuticsPairCorr
  0.68MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr

Moving against Precigen Stock

  0.58BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.44ESLAW Estrella ImmunopharmaPairCorr
  0.44PHVS Pharvaris BVPairCorr
  0.42OPT OptheaPairCorr
  0.41NAMS NewAmsterdam PharmaPairCorr
The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.
The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:
Check out the analysis of Precigen Correlation against competitors.
To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.57)
Revenue Per Share
0.018
Quarterly Revenue Growth
(0.59)
Return On Assets
(0.42)
Return On Equity
(1.29)
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.